Emma Wilson

Emma Wilson is a Scientist II at Cyprotex since July 2019, contributing to the drug metabolism group. Prior to this role, Emma held positions in ADME screening at York Bioanalytical Solutions and worked as a freelance pharmaceutical market analyst at Wilson Research & Insights LTD, specializing in extensive market analysis reports. Emma's experience includes a lengthy tenure as a Senior Scientist at GlaxoSmithKline from January 2003 to January 2017, where responsibilities encompassed the development and optimization of whole cell compound screening assays for various small molecule medicines across multiple target classes. Emma holds a BSc honours degree in Microbial Science from The University of Huddersfield, completed in 2002.